NASDAQ: CSBR
Champions Oncology Inc Stock Ownership - Who owns Champions Oncology?

Insider buying vs selling

Have Champions Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joel AckermanDirector2026-10-1569,794$1.60
$111.67kBuy

1 of 1

CSBR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CSBR insiders and whales buy or sell their stock.

CSBR Shareholders

What type of owners hold Champions Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael Maurice Brown168.43%23,442,589$115.34MInsider
Patrick J. Kerins134.71%18,750,000$92.25MInsider
Ravi Viswanathan134.71%18,750,000$92.25MInsider
Harry R. Weller134.71%18,750,000$92.25MInsider
Peter W. Sonsini134.71%18,750,000$92.25MInsider
Krishna Kittu Kolluri134.71%18,750,000$92.25MInsider
David M. Mott134.71%18,750,000$92.25MInsider
Peter J. Barris134.71%18,750,000$92.25MInsider
Ryan D. Drant134.71%18,750,000$92.25MInsider
Anthony A. Florence Jr.134.71%18,750,000$92.25MInsider

1 of 3

CSBR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CSBR0.00%100.00%Net BuyingNet Buying
FBIO0.02%49.61%Net BuyingNet Buying
RNXT0.02%10.44%Net Buying
TELO0.00%23.07%Net Buying
GOSS1.04%98.96%

Champions Oncology Stock Ownership FAQ

Who owns Champions Oncology?

Champions Oncology (NASDAQ: CSBR) is owned by 0.04% institutional shareholders, 2,080.89% Champions Oncology insiders, and 0.00% retail investors. Michael Maurice Brown is the largest individual Champions Oncology shareholder, owning 23.44M shares representing 168.43% of the company. Michael Maurice Brown's Champions Oncology shares are currently valued at $112.76M.

If you're new to stock investing, here's how to buy Champions Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.